Competition rules are aimed at safeguarding healthy competition between companies. For more than half a century the EU and its Member States have vigorously defended effective competition by pursuing and sanctioning anti-competitive agreements and abuses of dominant positions. The pharma sector has always been a focus area and increasingly so over the last decade. Prohibited are for example exchange of commercially sensitive information (sale figures, stock levels, production capacity, etc.), agreeing...
April 9, 2020
7 min read